sec filing
IP
NASDAQ · IPSC
Century Therapeutics, Inc.
Healthcare · Biotechnology
$1.98
Down-$0.12 (-6.06%)
Updated Sep 16, 2026, 10:09 PM
SID Score
5.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 50.91M
- P/E ratio
- -2.19
- Dividend yield
- 0.00%
- 52-week range
- $0.44 – $3.04
- Volume
- 359.64K
- Avg. volume
- 989.38K
Price performance
IPSC price history
1M range · 20 trading sessions · Daily adjusted prices
IPSC closed at $1.98 after 20 trading sessions, up 1.02% for the selected period.
- Last close
- $1.98
- Period change
- +1.02%
- Period low
- $1.94
- Period high
- $2.23
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $2.00 | $2.00 | $1.93 | $1.98 | 359.64K |
| Sep 14, 2026 | $1.96 | $2.02 | $1.89 | $2.00 | 507.6K |
| Sep 11, 2026 | $1.98 | $2.00 | $1.89 | $1.94 | 465.71K |
| Sep 10, 2026 | $2.03 | $2.03 | $1.91 | $1.94 | 510.03K |
| Sep 9, 2026 | $2.07 | $2.10 | $2.03 | $2.03 | 293.08K |
| Sep 8, 2026 | $2.10 | $2.13 | $2.03 | $2.07 | 228.15K |
| Sep 4, 2026 | $2.06 | $2.15 | $2.06 | $2.11 | 300.38K |
| Sep 3, 2026 | $2.13 | $2.13 | $2.05 | $2.09 | 349.61K |
| Sep 2, 2026 | $2.03 | $2.135 | $2.03 | $2.11 | 465.9K |
| Sep 1, 2026 | $2.00 | $2.04 | $1.98 | $2.03 | 320.47K |
| Aug 31, 2026 | $2.00 | $2.06 | $1.97 | $2.05 | 374.21K |
| Aug 28, 2026 | $2.23 | $2.25 | $1.99 | $2.025 | 630.55K |
| Aug 27, 2026 | $2.15 | $2.25 | $2.15 | $2.23 | 525.71K |
| Aug 26, 2026 | $2.17 | $2.17 | $2.10 | $2.14 | 313.57K |
| Aug 25, 2026 | $2.13 | $2.205 | $2.12 | $2.17 | 542.82K |
| Aug 24, 2026 | $2.08 | $2.145 | $2.03 | $2.12 | 360.77K |
| Aug 21, 2026 | $2.05 | $2.085 | $2.02 | $2.07 | 330.59K |
| Aug 20, 2026 | $2.07 | $2.09 | $2.019 | $2.02 | 314.08K |
| Aug 19, 2026 | $1.99 | $2.115 | $1.99 | $2.11 | 448.68K |
| Aug 18, 2026 | $1.94 | $1.98 | $1.90 | $1.96 | 389.16K |
Latest IPSC news
The latest Smart Investors Daily articles mentioning IPSC.
Stock researchResearch & News · SID Coverage
Loading stock research…

